Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease

Journal of the American Society of Nephrology

Volumn 13, Issue 1, 2002, Pages 134-141

  Zoccali, C ^a   Mallamaci, F ^a   Tripepi, G ^a   Benedetto, F A ^a   Cutrupi, S ^a   Parlongo, S ^a   Malatino, L S ^a   Bonanno, G ^a   Seminara, G ^a   Rapisarda, F ^a   Fatuzzo, P ^a   Buemi, M ^a   Nicocia, G ^a   Tanaka, S ^a   Ouchi, N ^a   Kihara, S ^a   Funahashi, T ^a   Matsuzawa, Y ^a  

^a CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; SECRETORY PROTEIN; TRIACYLGLYCEROL; VON WILLEBRAND FACTOR;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART PROTECTION; HEMODIALYSIS; HORMONE BLOOD LEVEL; HUMAN; KIDNEY FAILURE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK FACTOR; SEX DIFFERENCE; SURVIVAL;

EID: 0036139677     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Controlling the epidemic of cardiovascular disease in chronic renal disease: Where do we start?
2. Cardiovascular risk in uraemic patients: Is it fully explained by classical risk factors?
3. The role of leptin in human obesity and disease: A review of current evidence
4. Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus
5. Increased plasminogen activator inhibitor activity in non-insulin-dependent diabetic patients: Relationship with plasma insulin
6. cDNA cloning and expression of a novel adipose-specific collagen-like factor, apM1 (adipose most abundant gene transcript 1)
7. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity
8. Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein adiponectin
9. Metabolic and hemodynamic correlates of adiponectin, the most abundant adipocyte-derived protein, in human hypertension
10. High-performance liquid chromatographic method for measuring total plasma homocysteine levels
11. Prevalence of insulin resistance in metabolic disorders: The Bruneck study
12. The committee on M-mode standardization of the American Society of Echocardiography: Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements
13. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
14. Left ventricular mass and body size in normotensive children and adults: Assessment of allometric relations and impact of overweight
15. The relationship between leptin, the gene product of the ob gene, and nutritional status in hemodialysis patients
16. Leptin, body composition, and indices of malnutrition in patients on dialysis
17. Serum leptin concentrations correlate to plasma insulin concentrations independent of body fat content in chronic renal failure
18. Acute leptin regulation in end-stage renal failure: The role of growth hormone and IGF-1
19. Influence of long-term recombinant human erythropoietin (rHuEpo) therapy on plasma leptin and neuropeptide Y concentration in haemodialysed uraemic patients
20. Does the ob gene product leptin stimulate erythropoiesis in patients with chronic renal failure?
21. Isolation and characterisation of GBP28, a novel gelatin-binding protein purified from human plasma
22. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients
23. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages
24. Leptin is a negative acute phase protein in chronic hemodialysis patients
25. Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro
26. The pathogenesis of atherosclerosis: A perspective for the 1990s
27. Inflammation is associated with carotid atherosclerosis in dialysis patients